Medicamen Biotech Ltd
NSE:MEDICAMEQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medicamen Biotech Ltd
NSE:MEDICAMEQ
|
IN |
|
Grupo Ezentis SA
LSE:0QIH
|
ES |
|
A
|
Allied Gold Corp
TSX:AAUC
|
CA |
|
A
|
Avax SA
ATHEX:AVAX
|
GR |
|
Focus Universal Inc
NASDAQ:FCUV
|
US |
|
LTIMindtree Ltd
NSE:LTIM
|
IN |
|
Shanghai Dongzheng Automotive Finance Co Ltd
HKEX:2718
|
CN |
|
R
|
Ravad Ltd
TASE:RAVD
|
IL |
|
Ramelius Resources Ltd
ASX:RMS
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MEDICAMEQ's stock price target?
Not Available
MEDICAMEQ doesn't have any price targets made by Wall Street professionals.
What is Medicamen Biotech Ltd's Revenue forecast?
Projected CAGR
-2%
For the last 13 years the compound annual growth rate for Medicamen Biotech Ltd's revenue is 4%. The projected CAGR for the next 5 years is -2%.
What is Medicamen Biotech Ltd's Operating Income forecast?
Projected CAGR
29%
For the last 13 years the compound annual growth rate for Medicamen Biotech Ltd's operating income is 22%. The projected CAGR for the next 5 years is 29%.
What is Medicamen Biotech Ltd's Net Income forecast?
Projected CAGR
19%
The compound annual growth rate of Medicamen Biotech Ltd's net income for the next 5 years is 19%.
